.jpg)
Getting to Yes from Regulators to Payers and Beyond - the Decision-Maker Gauntlet
After Yes - Navigating the Rules of the Road in Today's Marketplace
Panel Session
Diagnostics
Lena Chaihorsky
Co-Founder & Vice President, Payer Innovation
Alva10
Rochelle Fink, MD, JD, MBA
Senior Health Science Specialist
U.S. Food and Drug Administration
Heather Brown
Senior Vice President, Market Access and Reimbursement
HeartFlow
Matt Tucker, MBA
Head of Sales and Marketing, VITAL & Enterprise Strategy
Highmark Health
The term "value" in health care has been difficult to define, yet stakeholders - from diagnostic test developers, to payers, to hospitals and health systems - are constantly seeking high value products and services that improve health outcomes for patients in clinical and cost-effective ways. However, the ability to define value is critical, particularly as the health care world moves toward more value based approaches to care delivery and reimbursement. This panel will present a range of perspectives on defining value, developing clinical evidence to support value claims and contemplating value based approaches for diagnostics.
